Vascular endothelial growth for in inflammatory bowel disease

International Journal of Colorectal Disease

Volumn 18, Issue 5, 2003, Pages 418-422

  Kapsoritakis, Andreas ^a   Sfiridaki, Aekaterini ^b   Maltezos, Efstratios ^c   Simopoulos, Kostantinos ^c   Giatromanolaki, Alexandra ^c   Sivridis, Efthimios ^c   Koukourakis, Michael L ^c  

^a UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^b Venizelion General Hospital   (Greece)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Crohn's disease; Ulcerative colitis; VEGF

Indexed keywords

BETA THROMBOGLOBULIN; EPIDERMAL GROWTH FACTOR; THROMBOCYTE FACTOR 4; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; FIBROBLAST; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA; INTESTINE MUSCLE; INTESTINE WALL; LYMPHOCYTE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; TISSUE REGENERATION; ULCER; ULCERATIVE COLITIS;

ADULT; BLOOD VOLUME; CASE-CONTROL STUDIES; COLON; HEMATOCRIT; HEMOGLOBINS; HUMANS; INFLAMMATORY BOWEL DISEASES; LINEAR MODELS; MIDDLE AGED; PLATELET COUNT; PLATELET FACTOR 4; THROMBOPOIETIN; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0041353890     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-003-0495-y     Document Type: Article

References (22)

1. Lee FD, MacDonald DG (1992) I diopathic inflammatory bowel disease. In: MacSween RNM, Whaley K (eds) Muir's textbook of pathology, 13th edn. Arnold, London, pp 711-716
2. Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18:4-25
3. Rachmilewitz D (1989) Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 298:82-86
4. Best WR, Becktel JM, Singleton JW, Kern F Jr (1976) Development of a Crohn's Disease Activity Index. National Cooperative Crohn's Disease Study. Gastroenterology 70:439-444
5. Zhang L, Scott P, Turley H, Leek R, Lewis CE, Gatter KC, Harris AL, Mackenzie IZ, Rees MP, Bicknell R (1998) Validation of anti-vascular endothelial growth factor (anti-VEGF) antibodies for immunohistochemical localization of VEGF in tissue ections: expression of VEGF in the human endometrium. J Pathol 185:402-408
6. Beck PL, Podolsky DK (1999) Growth factors in inflammatory bowel disease. Inflamm Bowel Dis 5:44-60
7. Kanazawa S, Tsunoda T, Onuma E, Majima T, Kagiyama M, Kikuchi K (2001) VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. Am J Gastroenterol 96:822-828
8. Bousvaros A, Leichtner A, Zurakowski D, Kwon J, Law T, Keough K, Fishman S (1999) Elevated serum vascular endothelial growth factor in children and young adults with Crohn's disease. Dig Dis Sci 44:424-430
9. Webb NJ, Bottomley MJ, Watson CJ, Brenchley PE (1998) Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin Sci (Colch) 94:395-404
10. Maloney JP, Silliman CC, Ambruso DR, Wang J, Tuder RM, Voelkel NF (1998) In vitro release of vascular endothelial growth factor during platelet aggregation. Am J Physiol 275:1054-1061
11. Gunsilius E, Petzer A, Stockhammer G, Nussbaumer W, Schumacher P, Clausen J, Gastl G (2000) Thrombocytes are the major source for soluble vascular endothelial growth factor in peripheral blood. Oncology 58:169-174
12. Verheul HM, Hoekman K, Luykx-de Bakker S, Eekman CA, Folman CC, Broxterman HJ, Pinedo HM (1997) Platelet: transporter of vascular endothelial growth factor. Clin Cancer Res 3:2187-2190
13. Kapsoritakis AN, Koukourakis MI, Sfiridaki A, Potamianos SP, Kosmadaki MG, Koutroubakis LE, Kouroumalis EA (2001) Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol 96:776-781
14. Martin JF, Bath PM, Burr ML (1991) Influence of platelet size on outcome after myocardial infarction. Lancet 338:1409-1411
15. Pizzulli L, Yang A, Martin JF, Luderitz B (1998) Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain. Eur Heart J 19:80-84
16. Kapsoritakis AN, Potamianos SP, Sfiridaki AI, Koukourakis MI, Koutroubakis IE, Roussomoustakaki MI, Manousos ON, Kouroumalis EA (2000) Elevated thrombopoietin serum levels in patients with inflammatory bowel disease. Am J Gastroenterol 95:3478-3481
17. Griga T, Voigt E, Gretzer B, Brasch F, May B (1999) Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease. Hepatogastroenterology 46:920-923
18. Griga T, May B, Pfisterer O, Muller KM, Brasch F (2002) Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease. Hepatogastroenterology 49:116-123
19. Abu-Ghazaleh R, Kabir J, Jia H, Lobo M, Zachary I (2001) Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells. Biochem, J 360:255-264
20. Bachelder RE, Crago A, Chung J, Wendt MA, Shaw LM, Robinson G, Mercurio (2001) Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res 61:5736-5740
21. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK, Waltenberger J, Voelkel NF (2000) Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 106:1311-1319
22. Brown KR, England KM, Goss KL, Snyder JM, Acarregui MJ (2001) VEGF induces airway epithelial cell proliferation in human fetal lung in vitro. Am J Physiol Lung Cell Mol Physiol 281:1001-1010